Skip to main content
ConductScienceScienceDex

ScienceDex / Researcher record

Colleen Doyle Cooper

From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.

FY2026 NIH rank #12,143
Unclaimed recordClaim profile
  • Early Career

NIH Funding · FY2026

Linked Award Amount
$1.7M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#12,143
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2024$998,3751#15,127
2025$1,228,9021#13,221
2026$1,701,5923#12,143

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20241 record
  2. FY20251 record
  3. FY2026 · selected3 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Colleen Doyle Cooper. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$1M

1 awards · administering

NIDDK

National Institute of Diabetes and Digestive and Kidney Diseases

$356.3K

1 awards · administering

NIAID

National Institute of Allergy and Infectious Diseases

$320.9K

1 awards · administering

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10320602Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2026 award records by amount

NIH award records listing Colleen Doyle Cooper as a PI. Multi-PI records show the full award amount for context.

  • 5R44CA298512-02R44Contact PI
    Development of CM-HZ01 as a non-alpha-IL2 therapeutic for the treatment of metastatic melanoma
    Celdara Medical, Llc
    $1M
    award amount
  • 1R43DK143897-01A1R43Contact PI
    Development of a Novel, Allogeneic Cell Therapy for Difficult to Treat IBD
    Celdara Medical, Llc
    $356.3K
    award amount
  • 1R43AI197698-01R43Contact PI
    Precision CAR-NK therapy for VK4-1 autoreactive B cells in autoimmune diseases: advancing treatment with preserved immune function.
    Celdara Medical, Llc
    $320.9K
    award amount

Award organization

Organizations that administered FY2026 awards listing Colleen Doyle Cooper as a PI.

FY2026 award administered by Celdara Medical, Llc (NH).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Celdara Medical, Llc
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding

Explore further

Find collaborators for Colleen Doyle Cooper

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →